75
Participants
Start Date
October 31, 2004
Study Completion Date
January 31, 2006
eculizumab
St. James Hospital, Haematology Department, Dublin
Ucl St. Luc, Hematology Department, Brussels
Royal Melbourne Hospital, Dept. of Clinical Haematology & Medical Oncology, Parkville
Universitatsklinik Basel, Division of Hematology, Basel
Princess Alexandra Hospital, Oncology Haematology Radiation Department, Woolloongabba
Queen Elizabeth Hospital, Dept. of Haematology, Woodville South
The Royal Perth Hosptial, Department of Haematology/Level 2, Perth
UMC St. Radboud, Dept. of Hematology, Nijmegen
NYU Clinical Cancer Center, New York
Memorial Sloan Kettering Cancer Center, New York
Presbyterian Medical Center, PENN Comprehensive Hemophilia & Thrombosis Program, Philadelphia
National Heart, Blood, and Lung Institute, National Institutes of Health, Bethesda
Johns Hopkins University Medical Center, Baltimore
Duke University Health System, Division of Cell Therapy, Heme Malignancies Program, Durham
Cleveland Clinic, Dept. of Clinical Research, Weston
Cleveland Clinic Foundation, Cleveland
Indiana University Cancer Pavilion, Div. of Hematology-Oncology, Hematological Malignancy Program/Immunology, Indianapolis
Azienda Ospedaliera Universitaria Careggi, Dipartimento di area critica medico-chirurgica, Florence
University of California at Los Angeles, Los Angeles
Umea University Hospital, Dept. of Internal Medicine 3, Section for Hematology, Umeå
Scripps Cancer Center, San Diego
City of Hope National Medical Center, Div. of Hematology & Bone Marrow Transplant, Duarte
Stanford University Medical Center, Division of Hematology, Stanford
Hartford Hospital, Cancer Clinical Research Office, Hartford
Massachusetts General Hospital, Boston
Washington University School of Medicine, Dept. of Internal Medicine/Division of Hematology, St Louis
University of Alberta, Cross Cancer Institute, Edmonton
Hospital De L'Hotel Dieu, Hematologie et Oncologie Medicale, Cedex
Hopital Saint-Louis, Centre G. Hayem-Secteur Bleu Porte 7, Laboratoire De Pathologie/Greffe de Moelle, Cedex
Universitatsklinikum Essen, Zentrum fur Innere Medizin, Essen
Universitatsklinik Greifswald, Innere Medizin C - Hamato-Onkologie, Greifswald
Medizinische Hochschule Hannover, Abt. Hamatologie/Onkologie, Zentrum fur Innere Medizin, Hanover
Saarland University Medical School, Internal Medicine 1, Homburg/Saar
Institut fur Klinische Transfusionmedizin und Immungenetik, Abtlg. Transfusionsmedizin des Universitatskinikums Ulm, Ulm
Ospedale San Martino, Dept. of Hematology, Genova
Ospedale Maggiore di Milano, Divisione di Ematologia, Milan
Universitar degli Studi di Napoli, Divisione di Ematologia, Azienda Universitar Policlinico, Napoli
Ospedale San Bortolo, Divisione di Ematologia, Vicenza
Lund University Hospital, Department of Internal Medicine, Section of Hematology, Lund
Royal Cornwall Hospital, Haematology Dept., Truro
Belfast City Hospital, Dept. of Haematology C Floor, Belfast
Leeds General Infirmary, D Floor Brotherton Wing, Leeds
St. George's Hospital, Department of Haematology, London
Lead Sponsor
Alexion Pharmaceuticals, Inc.
INDUSTRY